For embolization of lesions in the peripheral vasculature, including arteriovenous malformations, hypervascular tumours or endoleaks.
- Available in viscosities 12 cP, 18 cP and 34 cP and vial sizes of 1,5 ml und 3ml
- Very good, homogeneous visibility (homogeneous X-ray density)
- Sedimentation-reduced stability due to micronized tantalum
- Allows for prolonged injection times
SQUIDPERI is intended to the embolization of lesions in the peripheral vasculature, including arteriovenous malformations and hypervascular tumors. Class IIb CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC). Manufactured by EMBO-FLÜSSIGKEITEN A.G. Carefully read the instructions for use before use. First CE marking: 2013. The content of this document, in particular data, information, trademarks and logos are BALT SAS’s sole property © 2018 BALT and its affiliates, all rights reserved. All representation and/or reproduction, whether in part or in full, is forbidden and would be considered a violation of BALT SAS and its affiliates’ copyrights and other intellectual proprietary rights. Any complete or partial reproduction, representation, modification, publication, transmission or distortion of the services or the contents of this document, whoever owns it, is forbidden, to the exception of a single copy on a computer reserved to the exclusive use of the copyist. This document with associated pictures are non-contractual and are solely dedicated to healthcare professionals and BALT’s distributors (BALT’s supplier’s distributors). The products commercialized by BALT SAS shall exclusively be used in accordance with the instructions for use included in the boxes.